Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ACID CONCENTRATE A1263 - Health Canada Drug Approval Details

Approvals/Health Canada/ACID CONCENTRATE A1263

Authorized

STANDARD

ACID CONCENTRATE A1263

chief medical supplies ltd🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: d6b085d2cda6b5b3
Company: chief medical supplies ltd
Type: Standard

Approval Details

Approval Id: d6b085d2cda6b5b3
Drug Approval Canada Name: ACID CONCENTRATE A1263
Product Name: ACID CONCENTRATE A1263
Status: Marketed
Status Date: 2023-01-23
Original Market Date: 2023-01-23
Din: 02533871
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Haemodialysis
Schedule: Ethical
Ahfs: 40:34.00*
Atc Original: B05ZA HEMODIALYTICS, CONCENTRATES
Atc Name: b 05 za
Aig Number: 0617386208
Company Name: chief medical supplies ltd
Company Address: 411 19th St Se, Calgary, Alberta, Canada, T2E 6J7

Active Ingredients

ACETIC ACID

10.8 G / L

CALCIUM CHLORIDE

8.26 G / L

MAGNESIUM CHLORIDE

6.86 G / L

DEXTROSE

49.5 G / L

POTASSIUM CHLORIDE

10.1 G / L

SODIUM CHLORIDE

263 G / L

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

d6b085d2cda6b5b3

Type

Standard

Back to Health Canada Approvals